<DOC>
	<DOCNO>NCT00310713</DOCNO>
	<brief_summary>Persistence antibody kinetics B cell response healthy child vaccination MCC vaccine</brief_summary>
	<brief_title>Persistence Antibodies Kinetics B Cell Response Healthy Children After Vaccination With MCC Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Healthy child Known hypersensitivity vaccine product Any immunodeficiency , genetic anomaly severe acute chronic illness</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>13 Months</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Prevention Meningococcal Meningitis</keyword>
	<keyword>vaccine</keyword>
	<keyword>conjugate</keyword>
	<keyword>immunology</keyword>
	<keyword>child</keyword>
	<keyword>antibody persistence</keyword>
</DOC>